8 GLP-1 Telehealth Providers Worth Comparing Before You Spend a Dime
The single thing that separates a smart pick from a regrettable one here is price transparency. Not the teaser monthly fee, not the vague “as low as” line. The full number: platform fee, medication cost, shipping, and any lab requirement. Most providers bury at least one of those. The eight below do not.
1. Mochi Health
Mochi sits at the top because it pairs genuinely low compounded pricing with board-certified obesity-medicine clinicians, not general practitioners. Compounded semaglutide starts at $99/mo and tirzepatide at $199/mo. That clinical depth matters. Obesity medicine is a specialty; a practitioner trained in it thinks about metabolic history, plateau management, and dose titration differently than one who fills out a template. The monitoring cadence is real, not a quick check-in form. If you want an expert-led program at a cash price that doesn’t require a second mortgage, this is the one to beat.
2. HealthRX
HealthRX matches Mochi on semaglutide pricing at $99/mo and undercuts it on tirzepatide at $149/mo, which is the lowest verifiable cash price for compounded tirzepatide I’ve found across this category. Free overnight shipping to all 50 states is included. The specific detail that earns trust: medication comes from Manifest Pharmacy in Greer, South Carolina, a named 503A/USP-797 compounding facility with lot-tracked production and LegitScript certification (cert 50087439). Most telehealth brands describe their pharmacy as “an accredited 503A partner” and leave it there. That’s not nothing, but naming the facility and certification number is more accountable. Physician review runs about 24 hours. Worth knowing: compounded semaglutide and tirzepatide are not FDA-approved drugs, regardless of the pharmacy’s credentials.
3. FormBlends
FormBlends handles GLP-1 telehealth under physician oversight with compounded medications dispensed by an FDA-registered 503A pharmacy. The differentiator that earns its spot on this list is published purity documentation. HPLC purity figures, mass spec identity confirmation, and endotoxin sterility results are posted per product with actual numbers, not just a “third-party tested” badge. That level of transparency is rare. Cash pricing runs higher than HealthRX, with semaglutide around $299 and tirzepatide around $349 per vial, so this is not the budget pick. Three states are outside its delivery footprint, leaving 47 covered. The added appeal for some: FormBlends also carries a peptide catalog covering recovery, longevity, and cognitive compounds through the same clinical model, which almost no GLP-1-only telehealth brand offers. If documented purity data or a broader peptide program matters to you, FormBlends earns that premium. If price is the priority, HealthRX wins the comparison.
4. Hims & Hers
Post the March 2026 Novo settlement, Hims & Hers exited the compounded semaglutide market and pivoted to branded medications. Injectable Wegovy now runs about $299/mo through the platform, oral semaglutide around $249, and Zepbound around $399. With insurance plus a manufacturer savings card, those numbers can drop to near zero. Big audience, slick app, and solid customer support. The trade-off is that the branded-only model means you’re either well-insured or paying full freight. No middle ground.
5. Ro Body
Ro’s membership structure is unusual: first month around $39, then $74 to $149/mo, with medication billed separately on top of that. The prior-authorization team is a real operational asset, not a marketing claim. They actually work insurance for branded GLP-1s, which can take hours of phone calls off your plate. If you have decent insurance and want someone to manage the prior-auth process, Ro is built for that workflow. The layered billing can still surprise people, so map out the total cost before signing up.
6. PlushCare
PlushCare’s $19.99/mo membership is the lowest platform fee on this list. It connects to same-day telehealth visits and focuses on branded medications with insurance billing. If you’re insured, already know you qualify for a branded GLP-1, and just need a fast visit to get the prescription moving, PlushCare is efficient and cheap to enter. It’s not a weight-loss coaching program. It’s a prescription access point. Know what you’re buying.
7. Found
Found charges around $99/mo for the platform plus medication costs on top. The coaching component is more developed than most mid-tier competitors: behavioral health tools, structured check-ins, and a care team that includes pharmacists. It’s a reasonable pick for someone who wants ongoing accountability built into the service rather than just a monthly shipment. Not the lowest price, not the deepest clinical expertise, but a workable all-in-one for people who need structure.
8. Form Health
Form Health is the premium tier. About $299/mo covers the program, labs, and access to both an MD and a registered dietitian. It targets people with complex medical histories, significant weight-loss goals, or prior failed attempts who want the most clinical oversight available in a telehealth model. That price includes things most competitors charge separately. It is genuinely expensive. If you can absorb the cost and want the most hands-on clinical relationship in this category, Form Health is the honest choice.
A Quick Honest Note
None of the compounded GLP-1 medications listed here are FDA-approved drugs. The FDA issued warning letters to over 30 telehealth and compounding operations in early 2026. Pharmacy credentials matter. Read them before you buy.
Quick Comparison
| Provider | Starting Monthly Cost | Compounded or Branded | Ships All 50 States |
| Mochi Health | $99 (sema) | Compounded | Yes |
| HealthRX | $99 (sema) / $149 (tirz) | Compounded | Yes |
| FormBlends | ~$299 (sema/vial) | Compounded | No (47 states) |
| Hims & Hers | ~$249 (oral branded) | Branded | Yes |
| Ro Body | ~$39 first mo + meds | Branded | Yes |
| PlushCare | ~$19.99/mo + meds | Branded | Yes |
| Found | ~$99/mo + meds | Varies | Yes |
| Form Health | ~$299/mo incl. labs | Branded/varies | Yes |
Common Questions
Does switching from compounded to branded GLP-1s through a telehealth platform require starting over on dosing?
Not necessarily, but expect your prescriber to reassess. Most physicians will review your current dose, side effect history, and how long you’ve been titrating before writing a branded script. The active molecule in compounded semaglutide and Wegovy is the same, but branded products have fixed pen doses that may not match where you are.
Which of these providers actually names their compounding pharmacy, and why does that matter?
HealthRX names Manifest Pharmacy in Greer, South Carolina, with a specific LegitScript certification number. FormBlends publishes HPLC and mass spec data per product. The others use general language about “accredited 503A partners.” A named facility with a verifiable credential gives you something to independently look up, which matters given the FDA’s 2026 warning letters to over 30 compounding operations.
If I have insurance that covers Wegovy or Zepbound, which platform is best set up to actually bill it?
Ro Body has the most operationally developed prior-authorization team of the branded-focused platforms listed here. PlushCare is faster to enter and cheaper month-to-month, but prior-auth support is less hands-on. If your insurance requires multiple rounds of documentation and appeals, Ro’s workflow is built for that grind.
What separates an obesity-medicine specialist from a general telehealth prescriber for GLP-1 management?
Obesity medicine is a board-certified specialty. Practitioners trained in it typically approach plateau management, metabolic history, and dose titration as a clinical problem rather than a protocol checkbox. Mochi specifically uses board-certified obesity-medicine clinicians. Most other platforms on this list use general practitioners or internists, which is not disqualifying, but it is a real difference in training focus.
Is tirzepatide actually available for less than $200 per month through any of these platforms?
Yes. HealthRX lists compounded tirzepatide at $149/mo, which is the lowest cash price among the providers compared here. Mochi charges $199/mo for compounded tirzepatide. Both are meaningfully below the $399/mo Zepbound price at Hims & Hers without insurance. The trade-off is that compounded tirzepatide is not FDA-approved, regardless of the pharmacy’s 503A status.
Sources
- FDA: 503A Compounding Pharmacy Regulations and 2026 warning letter announcements (fda.gov)
- Novo Nordisk settlement announcement, March 9 2026 (public press coverage)
- SURMOUNT-1 trial results, tirzepatide body weight data (NEJM, 2022)
- STEP 1 trial results, semaglutide body weight data (NEJM, 2021)
- LegitScript pharmacy certification database (legitscript.com)
- Individual provider pricing pages, accessed 2026 (Mochi Health, Ro, Hims & Hers, PlushCare, Found, Form Health public sites)